4.3 Article

An increased risk of differentiated thyroid carcinoma in Iran with the 677C→T homozygous polymorphism in the MTHFR Gene

Journal

CANCER EPIDEMIOLOGY
Volume 35, Issue 1, Pages 56-58

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.canep.2010.10.001

Keywords

DTC; MTHFR 677C -> T; Genetic epidemiology

Funding

  1. Pasteur Institute of Iran

Ask authors/readers for more resources

Background: Methylenetetrahydrofolate reductase (MTHFR) involves in folic acid metabolism which influences DNA methylation. A single nucleotide polymorphism (SNP) called 677C -> T in MTHFR gene causes producing a thermolabile enzyme with reducing function and eventually defects DNA methylation. To determine association between germ-line polymorphism in MTHFR gene with differentiated thyroid carcinoma (DTC), this preliminary study was designed. Methods: This was a case-control study of 154 DTC patients and 198 cancer free individuals. Genotyping was performed by a multiplex PCR method and the frequencies of the 677C -> T SNP in cases and controls were compared. The risk estimation was done by multivariate logistic regression analysis. Results: Compared to CC genotype, an increased risk of DTC for the 677C -> T homozygous genotype was demonstrated (odds ratio [OR]: 2.08, 95% confidence interval [Cl]: 0.82-5.25). Also, multivariate analysis demonstrated an increased risk of DTC in recessive fashion (TT vs. CC or CT) (OR: 2.38, 95% Cl: 0.97-5.82). Conclusion: The MTHFR 677C -> T homozygous variant allele may be associated with increased risk of DTC. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available